奎扎替尼
Quizartinib (AC220)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
5 mg 10 mg 25 mg
Product Availability
3-5days
Price
$113.00
Member price
Product Availability
3-5days
Price
$163.00
Member price
Product Availability
3-5days
Price
$238.00
Member price
Quantity
- +
Product Overview
Product Name Quizartinib (AC220)
CAS950769-58-1
FormulaC29H32N6O4S
MW560.67
AppearanceWhite to off-white powder
Storage conditionDry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).
Security information
Product details

Quizartinib (formerly also know as AC-220; AC-010220, Vanflyta) is a novel, potent, 2nd-generation, and orally bioavailable FLT3 tyrosine kinase inhibitor for Flt3 (ITD/WT) with potential anticancer activity.With IC50s of 1.1 nM and 4.2 nM, respectively, it inhibits FLT3 in MV4-11 and RS4EL11 cells. With respect to KIT, PDGFRα, PDGFRβ, RET, and CSF-1R, it demonstrates a ten-fold greater selectivity. Currently, Daiichi Sankyo is developing quizartinib to treat acute myeloid leukemia. Quizartinib (Vanflyta) was approved in 2023 by FDA for treating AML.

Related literature
Related
Sorry, no related items
History
Anti-Human CD3xClaudin18.2 Bispecific Antibody ( Gresonitamab; AMG 910; )
Ramatroban
PD184352(Synonyms: CI-1040)
Quizartinib (AC220)
Pratensein
Romidepsin (Synonyms: FK 228; FR 901228; NSC 630176)
3-Deazaneplanocin A Hydrochloride (Synonyms: DZNep hydrochloride; NSC 617989 hydrochloride; 3-Deazaneplanocin hydrochloride;3-Deazaneplanocin A (DZNeP) HCl;NSC 617989 HCl)
Teuclatriol
DOTA-​NHS-ester
Troxacitabine (Synonyms: BCH 4556; L-OddC; SPD 758)